Literature DB >> 27466743

Depression and serum low-density lipoprotein: A systematic review and meta-analysis.

Jane E Persons1, Jess G Fiedorowicz2.   

Abstract

BACKGROUND: A cross-sectional association between depression and serum low-density lipoprotein (LDL) has been noted in the literature. This study aims to employ meta-analytic techniques to clarify the relationship between depression and serum LDL.
METHODS: Published articles through April 2015 were identified through systematic query of PubMed with follow-up manual searches. Data from 36 studies reporting mean difference and 7 studies reporting odds ratios were analyzed separately.
RESULTS: Meta-analysis of studies modeling serum LDL as a continuous measure demonstrates overall significantly lower serum LDL in depression (Mean difference=-4.29, 95% CI=-8.19, -0.40, p=0.03). Meta-analysis of studies modeling serum LDL as a categorical measure demonstrates a marginally significant lower odds of depression in the presence of low serum LDL relative to high serum LDL (OR=0.90, 95% CI=0.80, 1.01, p=0.08). LIMITATIONS: High heterogeneity was noted across sampled studies, which may be a function of variations in study design, participants sampled, or other factors. The potential for publication bias was also assessed.
CONCLUSIONS: This meta-analysis demonstrates a cross-sectional link between depression and low serum LDL.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cholesterol; Depression; Lipids; Low-density lipoprotein; Meta-analysis

Mesh:

Substances:

Year:  2016        PMID: 27466743      PMCID: PMC6201299          DOI: 10.1016/j.jad.2016.07.033

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  58 in total

1.  Depressive symptoms and C-reactive protein: the Cardiovascular Risk in Young Finns Study.

Authors:  Marko Elovainio; Liisa Keltikangas-Järvinen; Laura Pulkki-Råback; Mika Kivimäki; Sampsa Puttonen; Liisa Viikari; Leena Räsänen; Kristiina Mansikkaniemi; Jorma Viikari; Olli T Raitakari
Journal:  Psychol Med       Date:  2006-04-20       Impact factor: 7.723

2.  Low serum cholesterol and suicide.

Authors:  H Engelberg
Journal:  Lancet       Date:  1992-03-21       Impact factor: 79.321

3.  Depressive symptoms and metabolic control in African-Americans with type 2 diabetes.

Authors:  T L Gary; R M Crum; L Cooper-Patrick; D Ford; F L Brancati
Journal:  Diabetes Care       Date:  2000-01       Impact factor: 19.112

4.  Castelli risk indexes 1 and 2 are higher in major depression but other characteristics of the metabolic syndrome are not specific to mood disorders.

Authors:  Heber Odebrecht Vargas; Sandra Odebrecht Vargas Nunes; Décio Sabbatini Barbosa; Mateus Mendonca Vargas; Ariane Cestari; Seetal Dodd; Kamalesh Venugopal; Michael Maes; Michael Berk
Journal:  Life Sci       Date:  2014-03-06       Impact factor: 5.037

5.  Serum lipid profiles in major depression with clinical subtypes, suicide attempts and episodes.

Authors:  Tiao-Lai Huang
Journal:  J Affect Disord       Date:  2005-05       Impact factor: 4.839

6.  Cholesterol depletion induces dynamic confinement of the G-protein coupled serotonin(1A) receptor in the plasma membrane of living cells.

Authors:  Thomas J Pucadyil; Amitabha Chattopadhyay
Journal:  Biochim Biophys Acta       Date:  2007-01-12

7.  Serum cholesterol, apolipoprotein E genotype and depressive symptoms in elderly European men: the FINE study.

Authors:  Erik J Giltay; Arianne K B van Reedt Dortland; Aulikki Nissinen; Simona Giampaoli; Tineke van Veen; Frans G Zitman; Sinikka Bots; Daan Kromhout
Journal:  J Affect Disord       Date:  2008-11-05       Impact factor: 4.839

8.  Serum lipids : new biological markers in depression ?

Authors:  A Khalid; N Lal; J K Trivedi; P K Dalal; O P Asthana; J S Srivastava; A Akhtar
Journal:  Indian J Psychiatry       Date:  1998-07       Impact factor: 1.759

9.  Are cholesterol and depression inversely related? A meta-analysis of the association between two cardiac risk factors.

Authors:  Ju Young Shin; Jerry Suls; René Martin
Journal:  Ann Behav Med       Date:  2008-09-12

10.  Low HDL cholesterol associates with major depression in a sample with a 7-year history of depressive symptoms.

Authors:  Soili M Lehto; Jukka Hintikka; Leo Niskanen; Tommi Tolmunen; Heli Koivumaa-Honkanen; Kirsi Honkalampi; Heimo Viinamäki
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2008-06-25       Impact factor: 5.067

View more
  25 in total

1.  Depression Augments Plasma APOA4 without Changes of Plasma Lipids and Glucose in Female Adolescents Carrying G Allele of APOA4 rs5104.

Authors:  Qi Wei Guo; Yan Jun Si; Yi Lin Shen; Xu Chen; Mei Yang; Ding Zhi Fang; Jia Lin
Journal:  J Mol Neurosci       Date:  2021-01-05       Impact factor: 3.444

2.  Optimism and Lipid Profiles in Midlife: A 15-Year Study of Black and White Adults.

Authors:  Farah Qureshi; Jackie Soo; Ying Chen; Brita Roy; Donald M Lloyd-Jones; Laura D Kubzansky; Julia K Boehm
Journal:  Am J Prev Med       Date:  2022-01-20       Impact factor: 5.043

Review 3.  The Role of Lipid Biomarkers in Major Depression.

Authors:  Amy Parekh; Demelza Smeeth; Yasmin Milner; Sandrine Thure
Journal:  Healthcare (Basel)       Date:  2017-02-03

4.  Shared mechanisms between coronary heart disease and depression: findings from a large UK general population-based cohort.

Authors:  Golam M Khandaker; Verena Zuber; Jessica M B Rees; Livia Carvalho; Amy M Mason; Christopher N Foley; Apostolos Gkatzionis; Peter B Jones; Stephen Burgess
Journal:  Mol Psychiatry       Date:  2019-03-19       Impact factor: 15.992

Review 5.  Evidence-based umbrella review of 162 peripheral biomarkers for major mental disorders.

Authors:  André F Carvalho; Marco Solmi; Marcos Sanches; Myrela O Machado; Brendon Stubbs; Olesya Ajnakina; Chelsea Sherman; Yue Ran Sun; Celina S Liu; Andre R Brunoni; Giorgio Pigato; Brisa S Fernandes; Beatrice Bortolato; Muhammad I Husain; Elena Dragioti; Joseph Firth; Theodore D Cosco; Michael Maes; Michael Berk; Krista L Lanctôt; Eduard Vieta; Diego A Pizzagalli; Lee Smith; Paolo Fusar-Poli; Paul A Kurdyak; Michele Fornaro; Jürgen Rehm; Nathan Herrmann
Journal:  Transl Psychiatry       Date:  2020-05-18       Impact factor: 6.222

6.  Integrated Analysis Reveals Altered Lipid and Glucose Metabolism and Identifies NOTCH2 as a Biomarker for Parkinson's Disease Related Depression.

Authors:  Mei-Xue Dong; Xia Feng; Xiao-Min Xu; Ling Hu; Yang Liu; Si-Yu Jia; Bo Li; Wei Chen; You-Dong Wei
Journal:  Front Mol Neurosci       Date:  2018-08-31       Impact factor: 5.639

7.  Examining the Influence of Early Life Stress on Serum Lipid Profiles and Cognitive Functioning in Depressed Patients.

Authors:  Ágnes Péterfalvi; Nándor Németh; Róbert Herczeg; Tamás Tényi; Attila Miseta; Boldizsár Czéh; Maria Simon
Journal:  Front Psychol       Date:  2019-08-06

8.  Metabolomic signatures associated with depression and predictors of antidepressant response in humans: A CAN-BIND-1 report.

Authors:  Giorgia Caspani; Gustavo Turecki; Raymond W Lam; Roumen V Milev; Benicio N Frey; Glenda M MacQueen; Daniel J Müller; Susan Rotzinger; Sidney H Kennedy; Jane A Foster; Jonathan R Swann
Journal:  Commun Biol       Date:  2021-07-22

9.  Hypocholesterolemia is an independent risk factor for depression disorder and suicide attempt in Northern Mexican population.

Authors:  Marcela Segoviano-Mendoza; Manuel Cárdenas-de la Cruz; José Salas-Pacheco; Fernando Vázquez-Alaniz; Osmel La Llave-León; Francisco Castellanos-Juárez; Jazmín Méndez-Hernández; Marcelo Barraza-Salas; Ernesto Miranda-Morales; Oscar Arias-Carrión; Edna Méndez-Hernández
Journal:  BMC Psychiatry       Date:  2018-01-15       Impact factor: 3.630

10.  Physical Exercise in Major Depression: Reducing the Mortality Gap While Improving Clinical Outcomes.

Authors:  Martino Belvederi Murri; Panteleimon Ekkekakis; Marco Magagnoli; Domenico Zampogna; Simone Cattedra; Laura Capobianco; Gianluca Serafini; Pietro Calcagno; Stamatula Zanetidou; Mario Amore
Journal:  Front Psychiatry       Date:  2019-01-10       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.